FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2569920477> ?p ?o ?g. }

• W2569920477 endingPage "16" @default.
• W2569920477 startingPage "16" @default.
• W2569920477 abstract "To compare the efficacy of subconjunctival administration of bevacizumab and different doses of sunitinib malate in reducing corneal neovascularization (CNV).In this experimental study, central corneal cauterization was created in the right eye of fifty male Sprague-Dawley rats. On day 1 (1 week after cauterization), rats were randomly assigned into five treatment groups. Group control (n = 10) received subconjunctival injection of 0.02 ml of base saline solution. Group 1 (n = 10) received 0.02 ml of bevacizumab (25 mg/ml). Group 2, 3, and 4 (n = 10 for each group) were treated with 0.02 ml of sunitinib malate (10, 20, and 50 μg/ml, respectively). On days 1, 7, and 14, digital photographs of the cornea were taken, and the area of CNV was measured.During the 2-week follow-up, CNV area in treatment groups was less than in control group (P < 0.05). On day 7, corneal avascular area was highest in Group 3 at 63%. On day 14, the area of CNV in Groups 2 and 3 was less than in Group 1 (P = 0.031 and 0.011, respectively), but the difference between Groups 2 and 3 was not statistically significant (P = 0.552). The decreased CNV area on day 14 in Group 4 was significant in comparison to bevacizumab, but it was not significant on day 7 (P = 0.25 on day 7 and 0.002 on day 14).Subconjunctival sunitinib malate is more effective than bevacizumab in regressing CNV. This effect is more prominent on day 14." @default.
• W2569920477 created "2017-01-13" @default.
• W2569920477 creator A5007447653 @default.
• W2569920477 creator A5017466598 @default.
• W2569920477 creator A5027706948 @default.
• W2569920477 creator A5038127611 @default.
• W2569920477 creator A5047362909 @default.
• W2569920477 creator A5058572777 @default.
• W2569920477 creator A5065559208 @default.
• W2569920477 creator A5068925366 @default.
• W2569920477 creator A5069175966 @default.
• W2569920477 creator A5073783682 @default.
• W2569920477 creator A5077247245 @default.
• W2569920477 creator A5084584842 @default.
• W2569920477 date "2017-01-01" @default.
• W2569920477 modified "2023-09-26" @default.
• W2569920477 title "Comparison of different doses of subconjunctival sunitinib with bevacizumab in the treatment of corneal neovascularization in experimental rats" @default.
• W2569920477 cites W1964569584 @default.
• W2569920477 cites W1969933921 @default.
• W2569920477 cites W1970189151 @default.
• W2569920477 cites W1980922532 @default.
• W2569920477 cites W2003797682 @default.
• W2569920477 cites W2004082367 @default.
• W2569920477 cites W2007486439 @default.
• W2569920477 cites W2009203749 @default.
• W2569920477 cites W2010392784 @default.
• W2569920477 cites W2017529362 @default.
• W2569920477 cites W2027359865 @default.
• W2569920477 cites W2028160054 @default.
• W2569920477 cites W2033245558 @default.
• W2569920477 cites W2042261909 @default.
• W2569920477 cites W2069153798 @default.
• W2569920477 cites W2071980849 @default.
• W2569920477 cites W2077603264 @default.
• W2569920477 cites W2079289507 @default.
• W2569920477 cites W2090093512 @default.
• W2569920477 cites W2099087156 @default.
• W2569920477 cites W2100027888 @default.
• W2569920477 cites W2123334268 @default.
• W2569920477 cites W2153331460 @default.
• W2569920477 cites W2322225671 @default.
• W2569920477 cites W4241938099 @default.
• W2569920477 doi "https://doi.org/10.4103/1735-1995.200266" @default.
• W2569920477 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5367213" @default.
• W2569920477 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28458707" @default.
• W2569920477 hasPublicationYear "2017" @default.
• W2569920477 type Work @default.
• W2569920477 sameAs 2569920477 @default.
• W2569920477 citedByCount "2" @default.
• W2569920477 countsByYear W25699204772018 @default.
• W2569920477 crossrefType "journal-article" @default.
• W2569920477 hasAuthorship W2569920477A5007447653 @default.
• W2569920477 hasAuthorship W2569920477A5017466598 @default.
• W2569920477 hasAuthorship W2569920477A5027706948 @default.
• W2569920477 hasAuthorship W2569920477A5038127611 @default.
• W2569920477 hasAuthorship W2569920477A5047362909 @default.
• W2569920477 hasAuthorship W2569920477A5058572777 @default.
• W2569920477 hasAuthorship W2569920477A5065559208 @default.
• W2569920477 hasAuthorship W2569920477A5068925366 @default.
• W2569920477 hasAuthorship W2569920477A5069175966 @default.
• W2569920477 hasAuthorship W2569920477A5073783682 @default.
• W2569920477 hasAuthorship W2569920477A5077247245 @default.
• W2569920477 hasAuthorship W2569920477A5084584842 @default.
• W2569920477 hasBestOaLocation W25699204771 @default.
• W2569920477 hasConcept C118487528 @default.
• W2569920477 hasConcept C121608353 @default.
• W2569920477 hasConcept C126322002 @default.
• W2569920477 hasConcept C141071460 @default.
• W2569920477 hasConcept C2776694085 @default.
• W2569920477 hasConcept C2776882836 @default.
• W2569920477 hasConcept C2777397205 @default.
• W2569920477 hasConcept C2777802072 @default.
• W2569920477 hasConcept C2777844972 @default.
• W2569920477 hasConcept C2778271429 @default.
• W2569920477 hasConcept C2779490328 @default.
• W2569920477 hasConcept C2780394083 @default.
• W2569920477 hasConcept C2780917750 @default.
• W2569920477 hasConcept C2908861226 @default.
• W2569920477 hasConcept C42219234 @default.
• W2569920477 hasConcept C71924100 @default.
• W2569920477 hasConceptScore W2569920477C118487528 @default.
• W2569920477 hasConceptScore W2569920477C121608353 @default.
• W2569920477 hasConceptScore W2569920477C126322002 @default.
• W2569920477 hasConceptScore W2569920477C141071460 @default.
• W2569920477 hasConceptScore W2569920477C2776694085 @default.
• W2569920477 hasConceptScore W2569920477C2776882836 @default.
• W2569920477 hasConceptScore W2569920477C2777397205 @default.
• W2569920477 hasConceptScore W2569920477C2777802072 @default.
• W2569920477 hasConceptScore W2569920477C2777844972 @default.
• W2569920477 hasConceptScore W2569920477C2778271429 @default.
• W2569920477 hasConceptScore W2569920477C2779490328 @default.
• W2569920477 hasConceptScore W2569920477C2780394083 @default.
• W2569920477 hasConceptScore W2569920477C2780917750 @default.
• W2569920477 hasConceptScore W2569920477C2908861226 @default.
• W2569920477 hasConceptScore W2569920477C42219234 @default.
• W2569920477 hasConceptScore W2569920477C71924100 @default.
• W2569920477 hasIssue "1" @default.
• W2569920477 hasLocation W25699204771 @default.

• next